The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosisKristine E. Ensrud, B. Mitlak, Pierre Delmas et al.|ORBi (University of Liège)|1998Cited by 21
Raloxifene therapy for 3 years reduces the risk of incident vertebral fractures in postmenopausal womenPD Delmas, H K Genant, KE Ensrud et al.|ORBi (University of Liège)|1999Cited by 4